Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

1.3K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.3K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

823
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
823
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

763
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
763
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

385
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
385
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

491
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
491
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

443
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
443

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Symptoms of respiratory illness in wind players and their relationship to instrument hygiene.

Scientific reports·2026
Same author

Baseline characteristics from the EXCITING-ILD registry.

BMJ open respiratory research·2025
Same author

Hyper-reactivity of CD8<sup>+</sup> T cells and high expression of IL-3 correlates with occurrence and severity of Long-COVID.

Clinical immunology (Orlando, Fla.)·2025
Same author

[Postbronchoscopy psychosis associated with metabolic alkalosis].

Innere Medizin (Heidelberg, Germany)·2025
Same author

The Partial Pressure of Oxygen Under Long-Term Oxygen Therapy With Various Types of Face Masks.

Deutsches Arzteblatt international·2025
Same author

Alpha-1 antitrypsin deficiency associated with rare <i>SERPINA1</i> alleles p.(Phe76del) and p.(Asp280Val): A family study.

Respiratory medicine case reports·2024
Same journal

Deutsche medizinische Wochenschrift (1946)·2026
Same journal

["Not everything that looks like a tumor..." - Pulmonary tularemia with hilar lymphadenopathy].

Deutsche medizinische Wochenschrift (1946)·2026
Same journal

[Emergency management of sickle cell disease].

Deutsche medizinische Wochenschrift (1946)·2026
Same journal

[Hereditary dehydrated stomatocytosis (= hereditary xerocytosis) - Interesting hummingbird or clinically relevant diagnosis?]

Deutsche medizinische Wochenschrift (1946)·2026
Same journal

[Diagnosis of Congenital Hemolytic Anemias in Adults].

Deutsche medizinische Wochenschrift (1946)·2026
Same journal

[46-year-old female patient with right upper abdominal pain].

Deutsche medizinische Wochenschrift (1946)·2026
See all related articles

Related Experiment Video

Updated: Dec 29, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.7K

[Update Sarcoidosis].

Michael Pfeifer1,2,3, Marc Lepiorz2

  • 1Klinik für Pneumologie, Donaustauf.

Deutsche Medizinische Wochenschrift (1946)
|February 5, 2020
PubMed
Summary
This summary is machine-generated.

Sarcoidosis, a systemic granulomatous disease, can be progressive. Diagnosis utilizes clinical and imaging findings, with FDG-PET and cardiac MRI aiding assessment. Treatment is individualized, often involving corticosteroids and other immunosuppressants.

More Related Videos

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

685
Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
07:18

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Published on: June 13, 2019

7.3K

Related Experiment Videos

Last Updated: Dec 29, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.7K
Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

685
Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
07:18

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Published on: June 13, 2019

7.3K

Area of Science:

  • Immunology
  • Pulmonology
  • Systemic Inflammatory Diseases

Background:

  • Sarcoidosis is a systemic granulomatous disease with unclear etiology.
  • While often benign, a subset of sarcoidosis cases exhibit chronic progressive disease.
  • Accurate diagnosis and staging are crucial for effective patient management.

Purpose of the Study:

  • To review current diagnostic modalities for sarcoidosis.
  • To highlight the role of advanced imaging in assessing disease activity and cardiac involvement.
  • To discuss current therapeutic strategies and the individualized approach to immunosuppressive treatment.

Main Methods:

  • Review of clinical presentation and radiological imaging findings.
  • Emphasis on the utility of Fluorodeoxyglucose-Positron Emission Tomography (FDG-PET) for activity assessment.
  • Discussion of Magnetic Resonance Imaging (MRI) for cardiac sarcoidosis diagnosis.

Main Results:

  • Diagnosis relies on clinical evaluation and imaging.
  • FDG-PET and cardiac MRI are increasingly important for evaluating disease activity and cardiac manifestations.
  • Treatment decisions are patient-specific, based on severity and organ involvement.

Conclusions:

  • Sarcoidosis management requires a tailored approach.
  • Immunosuppressive therapy, including corticosteroids, methotrexate, and TNF-alpha inhibitors, is guided by disease severity.
  • Ongoing research is vital to further clarify sarcoidosis etiology and optimize treatment protocols.